Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
18.56
-0.94 (-4.82%)
May 18, 2026, 4:00 PM EDT - Market closed
AAPG Market Cap
AAPG has a market cap or net worth of $1.77 billion as of May 19, 2026. Its market cap has decreased by -20.76% in one year.
Market Cap
1.77B
Enterprise Value
1.70B
1-Year Change
-20.76%
Ranking
Category
Stock Price
$18.56
Market Cap Chart
Since the IPO on June 13, 2022, AAPG's market cap has increased from $554.36M to $1.77B, an increase of 219.63%. That is a compound annual growth rate of 34.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 1.77B | -28.55% |
| Dec 31, 2025 | 2.47B | 36.38% |
| Dec 31, 2024 | 1.81B | 82.20% |
| Dec 29, 2023 | 994.30M | 16.90% |
| Dec 30, 2022 | 850.58M | 53.44% |
| Jun 13, 2022 | 554.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADMA Biologics | 1.92B |
| Intellia Therapeutics | 1.91B |
| Mesoblast | 1.89B |
| Stoke Therapeutics | 1.87B |
| Sarepta Therapeutics | 1.85B |
| AnaptysBio | 1.84B |
| Sionna Therapeutics | 1.82B |
| Syndax Pharmaceuticals | 1.79B |